249 related articles for article (PubMed ID: 7589072)
1. Role of splenic B cells in the immune privilege of the anterior chamber of the eye.
Niederkorn JY; Mayhew E
Eur J Immunol; 1995 Oct; 25(10):2783-7. PubMed ID: 7589072
[TBL] [Abstract][Full Text] [Related]
2. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
Streilein JW; Niederkorn JY
J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
[TBL] [Abstract][Full Text] [Related]
4. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
Kawashima H; Yamagami S; Tsuru T; Gregerson DS
Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
[TBL] [Abstract][Full Text] [Related]
5. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
Wilbanks GA; Streilein JW
J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
[TBL] [Abstract][Full Text] [Related]
6. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
7. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
Wilbanks GA; Mammolenti M; Streilein JW
Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
[TBL] [Abstract][Full Text] [Related]
8. Genetic restrictions and cellular interactions in the induction of anterior chamber associated immune deviation (ACAID).
Ferguson TA; Kaplan HJ
Reg Immunol; 1988; 1(1):62-8. PubMed ID: 2978943
[TBL] [Abstract][Full Text] [Related]
9. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.
D'Orazio TJ; Mayhew E; Niederkorn JY
J Immunol; 2001 Jan; 166(1):26-32. PubMed ID: 11123273
[TBL] [Abstract][Full Text] [Related]
10. Expansion of B cells is necessary for the induction of T-cell tolerance elicited through the anterior chamber of the eye.
Ashour HM; Niederkorn JY
Int Arch Allergy Immunol; 2007; 144(4):343-6. PubMed ID: 17671393
[TBL] [Abstract][Full Text] [Related]
11. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).
D'Orazio TJ; Niederkorn JY
Immunology; 1998 Sep; 95(1):47-55. PubMed ID: 9767456
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Foxp3 in splenic CD8+ T cells from mice with anterior chamber-associated immune deviation.
Jiang L; Yang P; He H; Li B; Lin X; Hou S; Zhou H; Huang X; Aize K
Mol Vis; 2007 Jun; 13():968-74. PubMed ID: 17653037
[TBL] [Abstract][Full Text] [Related]
13. The antigen-bearing eye and the spleen are indispensable in maintaining anterior chamber-associated immune deviation.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):534-9. PubMed ID: 9040487
[TBL] [Abstract][Full Text] [Related]
14. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
15. CD4+PD-1+ T cells acting as regulatory cells during the induction of anterior chamber-associated immune deviation.
Meng Q; Yang P; Li B; Zhou H; Huang X; Zhu L; Ren Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4444-52. PubMed ID: 17003438
[TBL] [Abstract][Full Text] [Related]
16. High-dose cyclophosphamide inhibits anterior chamber-associated immune deviation (ACAID) and the production of extracellular antigen-specific T cell proteins induced by trinitrophenylated (TNP) spleen cells.
Wang Y; O'Rourke J; Cone RE
Cell Immunol; 1995 Oct; 165(2):284-8. PubMed ID: 7553893
[TBL] [Abstract][Full Text] [Related]
17. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
Hara Y; Okamoto S; Rouse B; Streilein JW
J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 abrogates anterior chamber-associated immune deviation.
Benson JL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
[TBL] [Abstract][Full Text] [Related]
19. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
[TBL] [Abstract][Full Text] [Related]
20. Intraocular injection of class II-restricted peptide induces an unexpected population of CD8 regulatory cells.
Kosiewicz MM; Streilein JW
J Immunol; 1996 Sep; 157(5):1905-12. PubMed ID: 8757308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
